Sleep Is a Medical Intervention

Deprive a healthy young adult of sleep for a few nights — not extreme, just four or five hours, the kind of week millions consider normal — and something measurable happens to their metabolism. The body handles glucose less well, drifting towards the pattern of early insulin resistance. Appetite hormones shift, nudging them to eat more, particularly the easy, calorie-dense things. Blood pressure runs higher. None of this requires a disease — it's just what insufficient sleep does to ordinary physiology, and it reverses when the sleep comes back.

That's the case, in miniature, for treating sleep as a medical variable rather than a lifestyle luxury. We've built a culture that sacrifices sleep to fit everything else in, and a wellness industry that treats it as a metric to optimise. Both miss the point. Sleep sits upstream of the metabolic and cardiovascular numbers this section keeps returning to — and unlike most things sold for those numbers, the evidence that it matters is genuinely strong.

What sleep does to the numbers that matter

Sleep isn't downtime; it's active maintenance. Across the night, the body regulates glucose and insulin sensitivity, blood pressure dips and recovers, hunger and fullness hormones are recalibrated, and the brain does its housekeeping. Cut the night short, and several systems this site cares about are affected at once.

The metabolic link is clearest. Short and poor-quality sleep are associated with worse glucose handling and a higher risk of type 2 diabetes, and the controlled experiments — restrict sleep and watch glucose metabolism deteriorate — give that association real teeth. Appetite regulation shifts too, which is why under-slept people tend to eat more; the failure isn't willpower, it's a nudged thermostat. And poor sleep, particularly when disrupted by untreated sleep apnoea, is linked to higher blood pressure and greater cardiovascular risk. The arteries don't get their nightly recovery.

Holding the epidemiology honestly

A note of caution, because sleep is a field where enthusiasm runs ahead of proof. Much of what we know about sleep and long-term health comes from observational studies — people who sleep poorly, followed over years, tend to fare worse. That's an association, and the usual problem applies: poor sleep travels with a crowd of other things (stress, shift work, depression, illness, deprivation), so some of what looks like "bad sleep causes disease" is partly "disease and disadvantage cause bad sleep."

What strengthens the case beyond association is the experimental work: short, controlled sleep-restriction studies showing glucose and blood pressure move in real time, with plausible mechanisms behind them. So the honest summary is neither breathless nor dismissive — the link between inadequate sleep and metabolic and cardiovascular harm is well-supported and biologically sensible, while the precise size of the effect, and how much is cause versus correlation, remains properly debated.

Insomnia has a first-line treatment, and it isn't a tablet

If sleep is genuinely poor — not occasionally short, but persistent difficulty falling or staying asleep that affects the day — the most important fact in this article is this: the first-line treatment for chronic insomnia is not a sleeping pill. It's cognitive behavioural therapy for insomnia, CBT-I.

CBT-I is a structured, time-limited programme that retrains the relationship between a person and their sleep — addressing the habits and thought patterns that keep insomnia going, the time spent lying awake, and the anxious vigilance that makes it self-sustaining. It is recommended ahead of medication precisely because it works at least as well in the short term and far better in the long term, without the dependence, tolerance and next-day grogginess that dog sleeping tablets. It's increasingly available on the NHS, including via digital programmes, and it's the thing to ask about — not because pills never have a role, but because the default has been backwards for years.

On the supplement everyone asks about: the evidence for over-the-counter sleep aids and melatonin in general adult insomnia is, for most people, weak and oversold, and melatonin has specific licensed uses rather than being a routine sleep tonic. The marketing is louder than the data.

Sleep hygiene, without the moralising

"Sleep hygiene" has become a faintly preachy phrase, so here's the unmoralised version. A few habits make sleep more likely for most people: a fairly consistent sleep and wake time, including at weekends; a wind-down period and a cool, dark, quiet room; daylight during the day and dimmer light in the evening; and going easy on caffeine in the afternoon and on alcohol close to bed — alcohol helps you fall asleep and then wrecks the second half of the night.

But two honest caveats. First, sleep hygiene helps ordinary, mild difficulties and lays a foundation — and is largely insufficient on its own for entrenched clinical insomnia, which is what CBT-I is for. Telling someone with a real insomnia disorder to "try a warm bath and no screens" is well-meaning and not enough. Second, the perfectionism the wellness industry has wrapped around sleep is itself counterproductive: lying in bed anxiously monitoring a sleep score is an excellent way to sleep worse. The goal is adequate, not optimised.

When poor sleep is a red flag, not a habit

Some sleep problems are not about hygiene or stress at all, and one matters enough to name plainly. Obstructive sleep apnoea — where the airway repeatedly collapses during sleep — is common, frequently undiagnosed, and a genuine driver of high blood pressure and cardiovascular risk. The pattern to recognise is the triad of loud snoring, witnessed pauses in breathing (usually reported by a bed partner), and significant daytime sleepiness — falling asleep in front of the television or, dangerously, at the wheel. That is not something to fix with a better pillow; it's a reason to see a doctor, because effective treatment exists and the stakes are real.

Practical takeaways

• Sleep sits upstream of glucose control, appetite regulation and blood pressure — treat it as a medical variable, not a luxury.
• The link to metabolic and cardiovascular harm is well-supported, though much of it is observational; the controlled experiments are what give it teeth.
• For chronic insomnia, the evidence-based first-line treatment is CBT-I, not sleeping tablets — and it's worth asking about specifically.
• Sleep-hygiene basics help mild difficulties but won't fix entrenched insomnia, and obsessive sleep tracking can make things worse.
• Loud snoring plus witnessed breathing pauses plus daytime sleepiness is a red-flag triad for sleep apnoea and warrants medical review.

What this doesn't mean

It doesn't mean every poor night damages your health, or that you can offset bad habits by chasing a perfect sleep score. Nor does it mean sleeping tablets never have a place — they sometimes do, for the right person, short-term, under guidance. It means the default approach to persistent sleep problems should start with the behavioural treatment and a check for underlying causes, not a supplement or a sedative.

When to seek medical advice

See your GP if poor sleep persists for weeks and affects your daytime functioning, mood or safety, or if it's bound up with low mood, anxiety or a physical health problem — these often need treating together. Seek review promptly if you have the snoring–pauses–sleepiness pattern of possible sleep apnoea, and don't start any sleep medication or supplement, melatonin included, without speaking to a pharmacist or GP.

A closing thought

Of all the things sold to make people healthier, the one with the best risk-to-benefit ratio is free, available tonight, and consistently treated as optional. Sleep won't trend, because you can't sell someone something they already own. But if the longevity-curious gave their sleep a fraction of the attention they give supplements, they'd feel the difference by Thursday.

Further reading and sources

• American Academy of Sleep Medicine (AASM) — guidelines on insomnia and CBT-I
• NICE — clinical knowledge summaries on insomnia and obstructive sleep apnoea
• NHS — sleep and tiredness; insomnia self-help and treatment information
• European Society of Cardiology — statements on sleep, sleep apnoea and cardiovascular risk
• Peer-reviewed reviews of sleep restriction, glucose metabolism and blood pressure